Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case–Control Study of the ALSPAC Longitudinal Birth Cohort

Schizophrenia genetics moves into the light

(2016) David Curtis   BRITISH JOURNAL OF PSYCHIATRY

Childhood body mass index and risk of schizophrenia in relation to childhood age, sex and age of first contact with schizophrenia

(2016) H.J. Sørensen et al.   EUROPEAN PSYCHIATRY

Blood biomarker discovery in drug-free schizophrenia: the contribution of proteomics and multiplex immunoassays

(2016) Sophie Sabherwal et al.   Expert Review of Proteomics

Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis

(2016) Grazia Rutigliano et al.   JOURNAL OF AFFECTIVE DISORDERS

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness

(2016) Anne N. Thorndike et al.   JOURNAL OF CLINICAL PSYCHIATRY

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

(2016) M O Trépanier et al.   MOLECULAR PSYCHIATRY

Schizophrenia risk from complex variation of complement component 4

(2016) Aswin Sekar et al.   NATURE

Schizophrenia genetics complements its mechanistic understanding

(2016) Elizabeth K Ruzzo et al.   NATURE NEUROSCIENCE

Linking genetic risk to pruning

(2016) Katherine Whalley   NATURE REVIEWS NEUROSCIENCE

Applications and Developments in Targeted Proteomics: From SRM to DIA/SWATH

(2016) Ruedi Aebersold et al.   PROTEOMICS

Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders

(2016) Virginie-Anne Chouinard et al.   PSYCHIATRY RESEARCH

Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells

(2016) Aaron Topol et al.   Cell Reports

Mediation of Developmental Risk Factors for Psychosis by White Matter Microstructure in Young Adults With Psychotic Experiences

(2016) Mark Drakesmith et al.   JAMA Psychiatry

Dysfunction in the coagulation system and schizophrenia

(2016) S Hoirisch-Clapauch et al.   Translational Psychiatry

Psychotic Experiences, Working Memory, and the Developing Brain: A Multimodal Neuroimaging Study

(2015) Leon Fonville et al.   CEREBRAL CORTEX

Review, Evaluation, and Discussion of the Challenges of Missing Value Imputation for Mass Spectrometry-Based Label-Free Global Proteomics

(2015) Bobbie-Jo M. Webb-Robertson et al.   JOURNAL OF PROTEOME RESEARCH

mapDIA: Preprocessing and statistical analysis of quantitative proteomics data from data independent acquisition mass spectrometry

(2015) Guoshou Teo et al.   Journal of Proteomics

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume

(2015) S G Fillman et al.   MOLECULAR PSYCHIATRY

Quantitative variability of 342 plasma proteins in a human twin population

(2015) Y. Liu et al.   Molecular Systems Biology

Multiplexed peptide analysis using data-independent acquisition and Skyline

(2015) Jarrett D Egertson et al.   Nature Protocols

Using data-independent, high-resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications

(2015) Tatjana Sajic et al.   Proteomics Clinical Applications

Brain Biomarkers of Vulnerability and Progression to Psychosis

(2015) Tyrone D. Cannon   SCHIZOPHRENIA BULLETIN

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

(2015) M K Chan et al.   Translational Psychiatry

Reduced protein synthesis in schizophrenia patient-derived olfactory cells

(2015) J A English et al.   Translational Psychiatry

Priming the Brain for Psychosis: Maternal Inflammation During Fetal Development and the Risk of Later Psychiatric Disorder

(2014) Mary Cannon et al.   AMERICAN JOURNAL OF PSYCHIATRY

Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis

(2014) Kuo-Chuan Huang et al.   BMC GENOMICS

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

STRING v10: protein–protein interaction networks, integrated over the tree of life

(2014) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project

(2014) Diana O. Perkins et al.   SCHIZOPHRENIA BULLETIN

Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis

(2014) Rachel Upthegrove et al.   SCHIZOPHRENIA RESEARCH

Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis

(2014) Franca Orsini et al.   Frontiers in Cellular Neuroscience

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life

(2014) Golam M. Khandaker et al.   JAMA Psychiatry

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia

(2014) N J M van Beveren et al.   Translational Psychiatry

Psychotic Experiences and Psychotic Disorders at Age 18 in Relation to Psychotic Experiences at Age 12 in a Longitudinal Population-Based Cohort Study

(2013) Stanley Zammit et al.   AMERICAN JOURNAL OF PSYCHIATRY

Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study

(2013) Jiří Masopust et al.   BMC Psychiatry

Multiplexed MS/MS for improved data-independent acquisition

(2013) Jarrett D Egertson et al.   NATURE METHODS

Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways

(2013) E. Schwarz et al.   SCHIZOPHRENIA BULLETIN

The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease

(2012) Alexander H. Stephan et al.   Annual Review of Neuroscience

Cohort Profile: The ‘Children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children

(2012) Andy Boyd et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls

(2012) Julian A.J. Jaros et al.   Journal of Proteomics

Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia

(2012) Yang Li et al.   Molecular BioSystems

At Clinical High Risk for Psychosis: Outcome for Nonconverters

(2011) Jean Addington et al.   AMERICAN JOURNAL OF PSYCHIATRY

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

(2011) Jürgen Cox et al.   JOURNAL OF PROTEOME RESEARCH

Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions

(2010) Nina C. Hubner et al.   JOURNAL OF CELL BIOLOGY

The environment and schizophrenia

(2010) Jim van Os et al.   NATURE

Early detection of psychosis: positive effects on 5-year outcome

(2010) T. K. Larsen et al.   PSYCHOLOGICAL MEDICINE

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum

(2009) Y Levin et al.   MOLECULAR PSYCHIATRY

fdrtool: a versatile R package for estimating local and tail area-based false discovery rates

(2008) K. Strimmer   BIOINFORMATICS

A unified approach to false discovery rate estimation

(2008) Korbinian Strimmer   BMC BIOINFORMATICS

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY